Rae Daddon

Associate
P: 416-597-4881
F: 416-593-3395
Email    PDF    VCard
  • Called to the Bar of Ontario, 2020
  • J.D., Queen’s University, 2019
  • B.Sc. (Honours), University of Toronto, 2011
Rae  Daddon Photo ©2025 Blaney McMurtry LLP
 Overview

Rae Daddon is an intellectual property (IP) and regulatory lawyer who is known for her strategic, business-oriented approach and her ability to provide clients with tailored solutions that address both commercial and compliance objectives.

Rae regularly acts for clients in patent, trademark and copyright disputes, as well as proceedings under the Patented Medicines (Notice of Compliance) Regulations. As a registered trademark agent, Rae offers comprehensive support in trademark prosecution, protection and enforcement. Rae also works closely with clients to develop and implement robust IP strategies that protect and maximize the value of their IP assets, enhance their competitive advantage and support long-term business objectives.

Rae’s regulatory practice is focused on providing support to clients in highly regulated industries such as pharmaceuticals, medical devices, natural health products, and food and cosmetics on Canadian regulatory and compliance issues. She advises clients on matters relating to establishment and product licensing, health products advertising and promotion, packaging and labeling requirements, Access to Information Act requests, and compliance with relevant legislation and regulatory standards.

She leverages her industry insight and deep understanding of regulatory and quality frameworks to provide practical guidance on navigating complex compliance matters. In a previous role, as a Regulatory Affairs and Quality Assurance (RA/QA) Consultant, Rae developed extensive experience in strategic planning, coordination and management of various regulatory and quality projects for pharmaceuticals, medical devices and natural health products, including New Drug Submissions, Abbreviated New Drug Submissions, Product Licence Applications and Clinical Trial Applications. In that role, she helped clients navigate issues relating to product and establishment licensing, formulary listings, product development and manufacturing, and pharmacovigilance (including Health Canada adverse drug reaction reporting and recalls).

In addition to her IP and regulatory expertise, Rae advises on various commercial matters, including the negotiation and drafting of license agreements, service agreements and commercial leases. She also works with clients to develop internal policies, operational frameworks and standard operating procedures that align with her clients’ business objectives.

Rae is an active member of the intellectual property and regulatory affairs community. She serves as a Member-at-Large for the Intellectual Property Section of the Canadian Bar Association (CBA) and is a member of the Intellectual Property Institute of Canada (IPIC) Continuing Professional Development (CPD) Committee. She is also a member of the Canadian Association of Professionals in Regulatory Affairs (CAPRA) and has authored articles for its magazine, News of Course (NOC).

 Education
  • J.D., Queen’s University, 2019
  • B.Sc. (Honours), University of Toronto, 2011
 Practice Areas  Called to the Bar
  • Called to the Bar of Ontario, 2020
 Assistant

Recognition

 Speaking

Speaking

  • Speaker, "Electronic Trial Prep for Junior Lawyers during COVID-19", Intellectual Property Institute of Canada
 Publications
 Memberships

Memberships

  • Law Society of Ontario
  • Canadian Bar Association
  • Ontario Bar Association
  • Intellectual Property Institute of Canada (IPIC)
  • Canadian Association of Professionals in Regulatory Affairs (CAPRA)
  • Pharmaceutical Sciences Group (PSG)
  • International Trademarks Association (INTA)
  • The Advocates’ Society
 Designations

Designations

  • Registered Trademark Agent (Canada)
DISCLAIMER

Thank you for your interest in contacting us by email.

Please be aware that contacting us via e-mail does not mean that the firm is acting for the sender of the e-mail. People do not become clients unless and until the firm agrees to act and that representation will be confirmed in a retainer agreement or retainer letter, in accordance with our usual policies. Unless you are an existing client, no information provided in an e-mail will be considered confidential. We ask that you do not send us specific questions on any matter until you receive confirmation that we are able to represent you.